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ttp://dx.doi.org/10.1016/j.ajpath.2014.01.035Cystic ﬁbrosis (CF) is a multiorgan disease caused by loss of a functional cystic ﬁbrosis transmembrane
conductance regulator (CFTR) chloride channel in many epithelia of the body. Here we report the
pathology observed in the gastrointestinal organs of juvenile to adult CFTR-knockout ferrets. CF
gastrointestinal manifestations included gastric ulceration, intestinal bacterial overgrowth with villous
atrophy, and rectal prolapse. Metagenomic phylogenetic analysis of fecal microbiota by deep
sequencing revealed considerable genotype-independent microbial diversity between animals, with the
majority of taxa overlapping between CF and non-CF pairs. CF hepatic manifestations were variable, but
included steatosis, necrosis, biliary hyperplasia, and biliary ﬁbrosis. Gallbladder cystic mucosal hy-
perplasia was commonly found in 67% of CF animals. The majority of CF animals (85%) had pancreatic
abnormalities, including extensive ﬁbrosis, loss of exocrine pancreas, and islet disorganization.
Interestingly, 2 of 13 CF animals retained predominantly normal pancreatic histology (84% to 94%) at
time of death. Fecal elastase-1 levels from these CF animals were similar to non-CF controls, whereas all
other CF animals evaluated were pancreatic insufﬁcient (<2 mg elastase-1 per gram of feces). These
ﬁndings suggest that genetic factors likely inﬂuence the extent of exocrine pancreas disease in CF
ferrets and have implications for the etiology of pancreatic sufﬁciency in CF patients. In summary, these
studies demonstrate that the CF ferret model develops gastrointestinal pathology similar to CF patients.
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Disclosures: None declared.Cystic ﬁbrosis (CF) is the most common life-threatening,
autosomal recessive, genetic disorder among Caucasians,
occurring in approximately 1 in 3500 births. Defects in the
cystic ﬁbrosis transmembrane conductance regulator (CFTR)
gene that disrupt function of this chloride channel cause ab-
normalities in electrolyte and ﬂuid movement across many
epithelia of the body, leading to viscous, poorly hydrated,
secretions.1 Although chronic bacterial infections in the lung
are the most signiﬁcant cause of mortality in CF, pathology in
multiple other organs contributes to the progression of dis-
ease and overall health of CF patients. These organs include
the intestine, pancreas, liver, and gallbladder for which
clinical and/or histological disease is seen in CF patients atstigative Pathology.
.frequencies of 10% to 90%.1e4 In the current study, we
evaluated gastrointestinal disease in juvenile and adult
CFTR-knockout ferrets.
Mouse models of CF have been critical to our under-
standing of CFTR function in several organs, however, CF
mice fail to develop spontaneous disease in the lung and
pancreas, and have relatively minor disease of the liver and
Sun et algallbladder.5,6 The recent creation of new CF pig and ferret
models has provided the ﬁeld with new tools to dissect CF
disease pathophysiology and the factors that inﬂuence dis-
ease severity in CF patients.7,8 Comparisons between CF
mouse, pig, and ferret models have clearly demonstrated
that species-speciﬁc differences in organ physiology and
CFTR biology inﬂuence the extent of pathology in major
organs affected in CF.9,10 For example, all newborn CF
models have intestinal pathology that manifests as meco-
nium ileus at birth in the case of CF pigs (100% of ani-
mals)11 and CF ferrets (75% of animals),12 or as intestinal
obstruction at weaning in the case of CF mice.5 By contrast,
pancreatic phenotypes at birth are highly variable between
species with disease being most severe in CF pigs,11 less
severe in CF ferrets,12,13 and absent in CF mice.5 Similarly,
CF pigs demonstrate histopathology in the gallbladder and
liver at birth,11 whereas disease in these organs is relative
minor in newborn CF ferrets12,13 and CF adult mice.5,6
Elucidating the differences in the severity of CF gastroin-
testinal disease at birth and in disease progression between
the various species may aid in dissecting genetic and envi-
ronmental factors that inﬂuence gastrointestinal disease
severity in CF patients.
Here, we report the phenotype of gastrointestinal organs
(pancreas, liver, gallbladder, stomach, and intestine) in older
CF animals reared on antibiotics until 6 months of age, or
the time at which they were euthanized due to severity of
disease. We have also evaluated the extent of bacterial
overgrowth in the CF intestine and the types of bacterial
ﬂora found in the intestine of non-CF and CF animals. Our
ﬁndings demonstrate that juvenile and adult CF ferrets
naturally acquire gastrointestinal disease at frequencies
similar to that observed in CF patients. Of great interest, a
small subset of CF animals was pancreatic sufﬁcient from
birth, implicating modiﬁer genes that can compensate for
the loss of CFTR in the exocrine pancreas. These studies
suggest that the CF ferret model could be useful for testing
therapies aimed at gastrointestinal organs and dissecting
how genetic variation inﬂuences disease in CF.
Materials and Methods
Rearing of CF Ferrets
The previously described CFTR exon-10 disrupted ferret
model was used for all studies.8 The colony of CFTRþ/
ferrets was backcrossed from sable to both albino and cin-
namon coat colors to increase genetic diversity. Heterozy-
gous matings were performed at Marshall Farms (North
Rose, NY) and pregnant jills were shipped to the University
of Iowa at 21 to 28 days gestation. After birth, kits were
rapidly genotyped as previously described.13 CF kits that
passed meconium were paired with a non-CF animal, and
generally all other kits were removed from the litter. CF and
non-CF kits were reared as previously described.14 Each CF
animal was paired with a non-CF sibling control and treated1310identically in terms of feeding, antibiotics, oral laxative, and
pancreatic enzyme supplementation. This approach was
used to control the variable clinical care of each CF animals
(ie, antibiotics to control lung infection and oral laxatives to
control gut obstruction). All kits were reared from birth on
20 mg/kg metronidazole s.c. (2 daily) and 4.0 mg/kg
piperacillin-tazobactam s.c. (2 daily), with each dose in
100 mL of saline. If weight gain decreased in CF animals
over a 12- to 18-hour period, both the non-CF control and
CF animals were placed on 10 mg/kg enroﬂoxacin s.c. (2
daily). If weight gain decreased a second time, the non-CF
control and CF animals were placed on 30 mg/kg cefazolin
s.c. (2 daily). This antibiotic protocol was required because
CF ferrets are highly susceptible to lung infections during
the early neonatal period.14 Porcine pancreatic enzymes
(Viokase-V; Neogen Corporation, Lexington, KY) supple-
mentation was initiated at approximately 20 to 30 days when
kits were transitioned to artiﬁcial nipple feeding. When an-
imals reached 21 weeks of age, the dose of antibiotics was
reduced by 25% per week until the animals were free from
antibiotics at 6 months of age.
Histology, Immunohistochemistry, and Morphometry
Standard histopathology analysis was performed on parafﬁn
sections from formalin-ﬁxed tissues. The tissues were
collected at the time of euthanasia (clinical death) and imme-
diately placed in 10% neutral buffered formalin for at least
72 hours. Tissues were then parafﬁn-embedded, sectioned
(4 mm) and stained with H&E or periodic acid-Schiff. Histo-
pathological examination was performed by a veterinary
pathologist, and age-matched CFTR/ and CFTRþ/þ;þ/
controls were used. Formalin-ﬁxed, parafﬁn-embedded pan-
creata were stained by immunohistochemistry for insulin and
glucagon (both from MP Biomedicals, Santa Ana, CA) as
previously described.13 Slides for morphometric assessment
were scanned with an Aperio ScanScope CS (Buffalo Grove,
IL) and images analyzed with Image-Pro Premier software
version 9.0 (Media Cybernetics, Rockville, MD). Morphom-
etry was performed to determine the percent normal pancreas
in two pancreatic sufﬁcient and two pancreatic insufﬁcient CF
animals. For the CF animals at approximately 250 days of age,
four sections from different areas of the pancreas were eval-
uated because the entire pancreas could not ﬁt onto one slide.
For CF animals at 19 days of age, three sections of the entire
pancreas (100 mm apart) were evaluated for morphometry
because the entire pancreas ﬁt onto one slide. Normal tissue
was deﬁned by an experienced veterinary pathologist as
lacking inﬂammation and structural changes associated with
CF pancreata.
Human CF and Non-CF Pancreatic Tissue
Formalin-ﬁxed human pancreatic tissues were obtained
from the National Disease Research Interchange (Philadel-
phia, PA). Tissue samples were collected from three non-CFajp.amjpathol.org - The American Journal of Pathology
GI Pathology in Adult CF Ferretsbrain dead donors patients: after head trauma, traumatic
injury, and traumatic brain injury. Six CF patient samples
were evaluated: three diagnosed with CF-related diabetes
and three that were not diagnosed with CF-related diabetes.
Fecal EL-1 Assays
Fecal elastase-1 (EL-1) assays were performed using a canine
EL-1 ELISA kit (ScheBo Biotech AG, Giessen, Germany)
according to the manufacturer’s instructions. Before ELISA,
fecal material was ﬁrst processed using an E1 Quick-Prep-
Canine extraction kit (ScheBo Biotech AG) according to the
manufacturer’s instructions. This fecal EL-1 assay detects
ferret EL-1, but does not cross-react with porcine EL-1 in
reconstitution assays performed with Viokase-V pancreatic
enzyme (Neogen Corporation).
Bacteriology of Intestinal Samples
At the time of necropsy, a portion of the duodenum and ileum
(containing fecal material) was homogenized in sterile saline
and a portion was plated directly onto blood agar, Mac-
Conkey agar, colistin and naladixic acid agar, colistin and
naladixic acid reducible agar, and chocolate agar in a four-
quadrant streak pattern. Cultures were incubated aerobicallyFigure 1 Histopathology in the CF ferret pancreas. Sections of pancreata fro
shown. Pancreas sections from a pair of 8-month-old non-CF (A and B) and CF (Ce
structurally intact islets is shown in B and D. Focal lobular destruction of part o
plugging with eosinophilic secretions (F). Boxed regions in A, C, and E are enla
representing the most common histological ﬁndings in three additional CF anim
enlargement and plugging with eosinophilic secretions. Epithelial-like cellular clu
GeL). Insets in A, C, G, I, and K are gross images of the pancreas (arrows). All se
(I); 100 mm (F and K); 75 mm (H); and 50 mm (B, D, J, and L).
The American Journal of Pathology - ajp.amjpathol.organd anaerobically for 24 to 48 hours at 35C. The remaining
tissue homogenate was mixed with glycerol to a ﬁnal con-
centration of 10% and frozen in aliquots in liquid nitrogen.
Assays for bacterial diversity were performed at the Iowa
State University Veterinary Diagnostic Bacteriology Labo-
ratory (Ames, Iowa) by an experienced bacteriologist
(J.M.K.) who subcultured unique colony morphologies and
performed preliminary classiﬁcation using biochemical re-
actions,15 and ﬁnal identiﬁcation was performed using 16S
sequencing and matrix-assisted laser desorption/ionization
time-of-ﬂight mass spectrometry ﬁngerprinting.16 Quantiﬁ-
cation of the major culturable bacteria from the ileum was
performed on frozen glycerol stock of tissue homogenates.
Serial dilutions of the homogenate were performed on blood
agar under aerobic and anaerobic conditions. The colony
forming unit titers were calculated and normalized to milli-
gram protein in the tissue homogenate.Fecal Microbiota Analysis by Shotgun Sequencing
Fecal DNA Extraction
DNA was extracted using the repeated bead beating plus
column (RBBþC) method as described by Yu and Morri-
son17 with modiﬁcations. Brieﬂy, by using a sterile scalpelm four CF and one non-CF animals ranging from 3 to 8 months of age are
F) ferrets (CF-1). A predominantly normal pancreas in both genotypes with
f the pancreas (arrow, E) is noted in CF-1 with ductular enlargement and
rged in B, D, and F, respectively. Photomicrographs of pancreatic sections
als older than 3 months (GeL). There is signiﬁcant ﬁbrosis with ductular
sters predominate in the CF pancreas (examples marked with arrowheads in
ctions were stained with H&E. Scale bars: 500 mm (A, C, E, and G); 200 mm
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Sun et alblade, 250 mg of frozen fecal sample was transferred into a
2 mL sterile tube containing 1 mL of lysis buffer (500 mmol/L
NaCl, 50 mmol/L Tris-HCl, pH 8.0, 50 mmol/L EDTA, 4%
sodium dodecyl sulfate, and 0.5 g of sterile DNA-free silica/
zirconia beads [BioSpec, Bartlesville, OK]). Subsequent
extraction was performed as described.17 The resulting DNA
samples were stored at 80C until sequenced.
Illumina Sequencing and Microbiota Analysis Using
Metagenomic Phylogenetic Analysis
Well-established methods for ultra-high throughput
sequencing were used to identify members of the bacterial
community in whole fecal samples from three pairs of CF and
non-CF ferrets, as described for human fecal samples.18
Brieﬂy, sequencing libraries were made from DNA pre-
parations using Illumina’s Nextera technology and were
sequenced on the MiSeq platform. There were 15 to 20
million paired-end reads (150 nucleotides long) generated per
sample, according to the manufacturer’s standards (IlluminaFigure 2 Islets are highly disorganized in the CF ferret and human pancreata.
marked. Each column of photomicrographs represents a different individual. Insulin
(B and F), non-CF human (C and G), and CF human (D and H). Glucagon immunosta
non-CF human (K and O), and CF human (L and P). Photomicrographs in EeH and
trauma. The CF patient in D and H died of respiratory failure and was not diagnosed
insulin and glucagon staining, were present within ﬁbrotic regions of the pancreas a
boundaries (arrows in B, D, J, and L). By contrast, non-CF islets were smaller wi
pancreas (A, C, I, and K). For additional histological examples, see Supplemental
1312Inc., San Diego, CA). Reads corresponding to ferret DNA
(http://www.ncbi.nlm.nih.gov; GenBank accession number
AEYP00000000.1) were ﬁltered from each sample before
analysis of the microbiome using the BMTagger program
generated by the NIH Human Microbiome Project (http://
www.mmnt.net/db/0/0/ftp.ncbi.nlm.nih.gov/pub/agarwala/
bmtagger, last accessed December 19, 2013). Metagenomic
Phylogenetic Analysis was used to proﬁle the composition
of microbial communities from metagenomic shotgun
sequencing data.19 Metagenomic Phylogenetic Analysis re-
lies on unique clade-speciﬁc marker genes identiﬁed from
3000 reference genomes and compares each metagenomic
read from a sample to this marker catalog to identify high-
conﬁdence matches at the species or higher taxonomic
levels. The total number of reads in each clade was normal-
ized by the nucleotide length of its markers to provide the
relative abundance of each taxonomic unit. This method
provided the identities and relative abundances of bacterial
taxa identiﬁed in each sample.Sections of pancreata from non-CF and CF ferrets and humans are shown as
immunostaining of pancreatic sections from non-CF ferret (A and E), CF ferret
ining of pancreatic sections from non-CF ferret (I and M), CF ferret (J and N),
MeP emphasize islet structure. The non-CF patient in C and G died of head
with cystic ﬁbrosis-related diabetes. CF ferret and human islets, identiﬁed by
nd characterized by large clusters of endocrine cells with poorly deﬁned islet
th well-deﬁned boundaries and were more evenly dispersed throughout the
Figure S2. Scale bars: 500 mm (AeD and IeL); 50 mm (EeH and MeP).
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This study was performed according to protocols approved
by the Institutional Animal Care and Use Committee (Uni-
versity of Iowa). Human pancreatic tissues were obtained
from the National Human Tissue Resource Centerwith IRB
approval (University of Iowa).
Results
Signiﬁcant Pancreatic Remodeling Occurs in Most
Juvenile and Adult CF Ferrets
Exocrine pancreatic insufﬁciency signiﬁcantly impacts the
health and nutrition of approximately 85% to 90% of CF
patients.20,21 Both exocrine and endocrine pancreatic disease
contribute to malnutrition and the development of diabetes in
CF patients.21,22We recently reported that juvenile CF ferrets
develop CF-related diabetes with many of the phenotypes
observed in CF patients.13 These studies reported a signiﬁ-
cant loss (approximately 50%) in islet mass of CF ferrets
within the ﬁrst month of age. In the current study, we eval-
uated the histopathology of the pancreas in older CF and non-
CF animals (Figure 1). Eighty-ﬁve percent (11 of 13) of CF
animals had signiﬁcant loss of the exocrine pancreas with
associated ﬁbrosis, ductal proliferation, and plugging of
intralobular ducts (Figure 1, GeL). Interestingly, two CF
animals (CF-1 and CF-12) had pancreata that were largely
histologically normal (Figure 1, AeD, and SupplementalFigure 3 A small subset of CF ferrets are pancreatic sufﬁcient. A: Morphom
pancreatic sufﬁcient (PS) or pancreatic insufﬁcient (PI) based on fecal EL-1 le
analysis of three to four nonoverlapping sections from each animal. B: Fecal EL-1
Indicated amount of Viokase-V pancreatic enzymes were spiked into 1 g of CF
evaluated for EL-1 activity. D and E: Fecal EL-1 levels at various ages from the ind
(CF-1 and CF-12) demonstrated near-normal pancreatic histology. The arrowhea
placed on Viokase-V pancreatic enzymes (ie, including all time points past the
pendent CF and non-CF control animals for three age groups as indicated. Compar
a signiﬁcant increase in 0 to 30 versus 31 to 80 days (P < 0.001), but not 31 t
*P < 0.0001 between genotypes by Student’s t-test. Dagger indicates two tim
considered to be pancreatic sufﬁcient in CF humans).
The American Journal of Pathology - ajp.amjpathol.orgFigure S1, AeG). However, each of these CF animals also
had focal lobules with extensive loss of exocrine parenchyma
and cystic dilation of ducts similar to that seen in other CF
animals (Figure 1, E and F, and Supplemental Figure S1, H
and I). These ﬁndings demonstrate that the ferret model re-
tains the variability in pancreatic phenotypes also seen in CF
patients,23 where 10% to 15% of CF patients retain partial or
complete exocrine pancreas function.
Similar to the exocrine pancreas, there was signiﬁcant
remodeling of the endocrine pancreas in all CF animals,
except CF-1 and CF-12 (compare Figure 1, AeD, to panels
GeL). Islets in most CF animals were poorly organized
(Figure 1, H, J, and L) in variably sized clusters surrounded
by thick bands of ﬁbrous tissue that replaced most of the
acinar mass of the pancreas. Immunostaining for insulin and
glucagon revealed that these cellular clusters in the CF
pancreas were indeed disorganized islets composed of beta
and alpha cells (Figure 2, A, B, E, F, I, J, M, and N, and
Supplemental Figure S2, B, C, E, F, H, I, K, and L). When
compared to human CF pancreas, similar disorganization of
islet structure within ﬁbrotic regions of the pancreas was
observed (Figure 2, C, D, G, H, K, L, O, and P, and
Supplemental Figure S2, A, D, G and J).A Small Subset of CF Ferrets is Pancreatic Sufﬁcient
Morphometric analysis demonstrated that CF-1 and CF-12
had 94% and 84% normal pancreatic histology, respectivelyetric analysis of pancreatic histopathology in four CF animals that were
vels. The mean percentage of normal pancreas (SEM) is shown for the
levels at various ages from CF-14 and its age-matched non-CF control. C:
feces lacking EL-1 activity or non-CF feces and the samples were then
icated CF animals and their age-matched non-CF control. These CF animals
d (B and D) marks the age at which both the CF and non-CF animal were
arrowhead). F: Summary of fecal EL-1 levels (means  SEM) for N inde-
ison of non-CF fecal EL-1 levels between various age brackets demonstrated
o 80 versus 81 to 150 days (P Z 0.448), time points by Student’s t-test.
e points for which fecal EL-1 levels dipped below 200 mg/g feces (level
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Sun et al(Figure 3A). The ﬁnding that 15% of the CF ferrets
analyzed had largely normal pancreatic histology raised the
possibility that these CF animals were pancreatic sufﬁcient
from birth. To this end, we evaluated fecal elastase-1 (EL-1)
levels in samples collected from CF animals with abnormal
and largely normal pancreatic morphology at the time of
death. All CF ferrets, with the exception of CF-1 and CF-12,
had fecal EL-1 levels <2 mg EL-1/g feces at all time points
evaluated (Figure 3, B and F), regardless of whether animals
were fed oral porcine pancreatic enzymes (Viokase-V)
(Figure 3B). This level of fecal EL-1 in CF animals was
>1000-fold lower than non-CF controls. Reconstitution
experiments spiking various amounts of Viokase-V into CF
feces lacking immunoreactive EL-1, or non-CF feces con-
taining signiﬁcant immunoreactive EL-1, did not alter EL-1
ELISA results (Figure 3C). In contrast to most CF animals,
the two CF animals with largely normal pancreatic mor-
phology (CF-1 and CF-12) had levels of fecal EL-1 that did
not differ from non-CF control littermates (Figure 3, D and
E). These ﬁndings demonstrate that a small subset of CF
ferrets is pancreatic sufﬁcient. Although 2 of 13 CF animals
evaluated in this study were pancreatic sufﬁcient, the overall1314prevalence of this pancreatic sufﬁcient phenotype in the CF
colony is likely much less frequent. This conclusion is based
on the ﬁnding that CF-1 and CF-12 had growth curves from
birth that were similar to non-CF controls and the fact the
frequency of this observation in our rearing experience is
approximately 1% to 2%.
Gallbladder Abnormalities Are More Common than Liver
Abnormalities in Older CF Ferrets
Gallbladder disease occurs in approximately 30% of CF
patients. Although newborn CF ferrets demonstrated little
gallbladder pathology,12 the majority of CF ferrets older
than 1 month of age demonstrated signiﬁcant mucous
changes (78%) and mucosal proliferation (89%). In these
cases (Figure 4, GeL), there was often thickening of the
gallbladder wall due to mucosal proliferation with the for-
mation of cystic structures that were variably sized and
contain eosinophilic homogenous material conﬁrmed to be
mucus by periodic acid-Schiff staining. Grossly, the CF
gallbladder was dark in appearance in cases where histo-
pathology was identiﬁed (Figure 4, G and J). In one CF caseFigure 4 Gallbladder abnormalities predomi-
nate in CF ferrets. Gross images of the liver and
gallbladder and histological sections of the gall-
bladder from three CF animals and one non-CF
animal, ranging from 3 to 8 months of age. Each
row of photomicrographs represents a different
animal. Gallbladders from non-CF (AeC) and CF
(DeF) 8-month-old ferrets (CF-1). Gross appear-
ance of the gallbladder in the non-CF animal (A) is
indistinguishable from the CF animal (CF-1) (D).
Histologically, the gallbladder between this non-CF
(B and C) and CF animal (EeF) was also quite
similar, with the only differences being decreased
mucosal folds in the CF animal. Gallbladders from
two additional CF animals older than 3 months of
age represent the most commonly seen pathology
(GeL). Gross appearance of the gallbladder is dark
and blue in color in both CF animals (G and J).
Multifocal hepatic necrosis (arrowheads, G). His-
tologically, the gallbladder in these CF animals (H,
I, K, and L) demonstrates mucus accumulation
(asterisks) and mucosal proliferation that formed
cyst-like structures. All sections are stained with
periodic acid-Schiff. Asterisks denote demon-
strated mucus accumulation in CF gallbladders
(H, I, K, and L). Scale bars: 200 mm (B, E, H, and
K) and 100 mm (C, F, I, and L). gb, gallbadder.
ajp.amjpathol.org - The American Journal of Pathology
GI Pathology in Adult CF Ferrets(CF-1), the animal with a predominantly normal pancreas,
the gallbladder was grossly and histologically very similar
to the non-CF control (Figure 4, AeF). However, even in
this case there were fewer mucosal folds and evidence for
multifocal cystic structures (Figure 4, E and F). Although no
clear association between pancreatic sufﬁciency and gall-
bladder disease in CF patients has been noted, it is inter-
esting that the older CF animal that appeared pancreatic
sufﬁcient also had a fairly normal gallbladder. There were
no gallbladder abnormalities observed in CF animals that
were less than 1-month-old (Table 1).
Liver abnormalities are not uncommon in CF patients and
are characterized by biliary cirrhosis (25%), hepatic stea-
tosis (30%), and clinical cirrhosis (5%).2,24,25 Although
newborn CF ferrets demonstrated consistent abnormalities
in liver enzymes and bile plugging at birth,12,13 histopath-
ological abnormalities in older CF ferrets were highly var-
iable. The majority of both non-CF (75%) and CF (67%)
animals demonstrated minor-to-moderate portal lymphoid
aggregates (Figure 5, AeD and F). Biliary ducts were
generally unremarkable except for rare luminal cell debris
and rare lymphocytes within the epithelium. There were 3
of 10 CF animals older than 1 month of age that demon-
strated hepatic pathology not observed in non-CF controls
(Table 1). These included multifocal mid-zonal necrosis
(Figures 4G and 5E) in CF-4 and lipid vacuoles consistent
with steatosis (Figures 5, G and H, and 4J) in CF-3 and
CF-10. The pattern of hepatic necrosis in CF-4 is atypical of
human CF liver disease. The cause of the necrosis is un-
known, however, sepsis can induce hepaticmidzonal necrosisTable 1 Summary of CF Animals Evaluated and Disease States
CF Ferret ID Life span (days) Antibiotics Liver
CF-1 257 6 months None
CF-2 359 6 months None
CF-3 120 OTD FL
CF-4 100 OTD MFN
CF-5 94 OTD None
CF-6 253 6 months None
CF-7 35* OTD None
CF-8 32* OTD None
CF-9 22 OTD None
CF-10 40 OTD FL
CF-11 68 OTD None
CF-12 19 OTD FL, G
CF-13 19 OTD BH, BF, BDP
CF-14 >200 6 months
Abnormaly 39%
*Animals were sacriﬁced due to a rectal prolapse.
yThe percentage of CF animals with any histological abnormalities is giving.
zThis number reﬂects uniform histological abnormalities in the pancreas because
sufﬁcient animals in the extent of pancreatic ﬁbrosis and exocrine destruction. CF
histological destruction of the exocrine pancreas.
BA, bacteria adherent to mucosal epithelium; BDP, bile duct plugging; BF, bil
plugging; DMF, decreased mucosal folds; ED, interstitial edema; EXD, exocrine de
with mucous; MA, mucus accumulation; MFN, multifocal midzonal necrosis; MP, mu
antibiotics until death; PI, pancreatic insufﬁcient; PS, pancreatic sufﬁcient; UC,
The American Journal of Pathology - ajp.amjpathol.organd/or centrilobular necrosis due to hypovolemic shock.26e28
Oil red O stain conﬁrmed hepatic steatosis in 20% of CF
animals greater than 1 month of age (Figure 5, M and N). To
assess whether fat accumulation was a consistent ﬁnding in
CF animals, we measured the triglyceride content in six CF
animals. These results conﬁrmed a correlation between his-
tological hepatic steatosis (Figure 5, M and N) and elevated
hepatic triglycerides (Figure 5O). Two of three CF animals
younger than 1 month of age demonstrated histological evi-
dence of hepatic steatosis, biliary hyperplasia, biliary ﬁbrosis,
and/or bile duct plugging (Figure 5, IeL, and Table 1).
Bacterial Overgrowth in the CF Intestine Was
Accompanied with Villous Atrophy and Crypt Mucous
Plugging
Approximately 75% of newborn CF kits are born with
meconium ileus,12 suggesting that the intestinal phenotype
may be more severe than that observed in CF patients.
Consistent abnormalities in the small intestine of CF ferrets
older than 1 month included villous atrophy with blunting
and fusion in 50% of animals (Figure 6 and Table 1). All CF
animals had lymphoplasmacytic inﬂammation within the
lamina propria. More severe villous atrophy was associated
with marked lymphoplasmacytic inﬂammation that extended
into the epithelium. Intestinal inﬂammation of varying de-
grees was also noted in some of the non-CF controls; how-
ever, villous atrophy was not a feature. Crypt dilatation with
the accumulation of periodic acid-Schiff-positive mucin
staining was common to all CF animals older than 1 month ofPancreas Gallbladder Intestine Stomach
94% normal, PS DMF CMP None
F, EXD, PI MA, MP VA, CMP None
F, EXD, PI MA, MP VA, CMP, BA None
F, EXD, PI MA, MP VA, CMP, BA ED
F, EXD, PI MA, MP VA, CMP, BA ED, UC, GD
F, EXD, PI MA, MP CMP, BA None
F, EXD, PI NE CMP GD
F, EXD, PI MP VA, CMP None
F, EXD, PI None None None
F, EXD, PI MA, MP CMP ED
F, EXD, PI MA, MP CMP GD
84% normal, PS None BA None
F, EXD, PI None None None
PI
85%z 77% 85% 39%
there was a clear distinction between pancreatic insufﬁcient and pancreatic
animals (86%) were pancreatic insufﬁcient based on fecal EL-1 levels and
iary ﬁbrosis; BH, biliary hyperplasia; CF, cystic ﬁbrosis; CMP, crypt mucous
struction; F, ﬁbrosis; FL, fatty liver; G, glycogen; GD, fundic gland dilation
cosal proliferation; NE, not evaluated as sample was not harvested; OTD, on
ulceration of gastric mucosa; VA, villus atrophy.
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Figure 5 Hepatic abnormalities are diverse and infrequent in CF ferrets. Liver sections from two non-CF animals (A, B, and M) and three CF animals (CeL
and N). Unique animals are depicted in panels A and B, C and D, E and F, G, H, and N, IeL, and M. All animals range from 3 to 8 months in age, except for the
19-day-old CF animal in IeL. Arrowheads in E mark the boundaries of hepatic necrosis. Boxed regions in A and C are enlarged in B and D, respectively. Higher
magniﬁcation photomicrographs of non-CF (M) and CF (N) littermates demonstrating lipid droplet accumulation in hepatocytes of the CF animal. The same CF
animal is presented in G, H, and N. Insets are oil red O stained sections from the same animal demonstrating lipid droplets in red, non-CF (M) and CF (N).
Hepatic triglycerides from CF and control non-CF littermates (O). Tissues from the animals marked by a red data point are shown in M and N. Data represents
means  SEM; NZ 6 independent animals. All sections representing the main panels were stained with H&E. Scale bars: 1 mm (A and C); 200 mm (B, D, H, and
I); 100 mm (EeG and JeL); and 25 mm for both main panel and inset (M and N). BDP, bile duct plugging; BF, biliary ﬁbrosis; BH, biliary hyperplasia.
Sun et alage and generally not observed in non-CF controls (Figure 6,
C, F, I, and L). The lumen of the CF small intestine was often
dilated by ingesta and contained signiﬁcantly greater number
of bacterial colonies, often adhered to the epithelial surface and
within the ingesta, conﬁrmed by colony forming unit titers of
intestinal tissue and Gram stain (Figure 7, A, CeH). Both
aerobic and anaerobic titers of bacteria cultured from the small
intestine (at the level of the ileum) were signiﬁcantly higher in
CF animals (>103-fold) as compared to controls (Figure 7A).
Additionally, several types of bacteria were cultured from the
intestine that distinguished CF or non-CF animals (Figure 7B
and Table 2). Importantly, all CF and non-CF pairs (Table 1)
were reared identically in terms of antibiotic treatments.
Using an alternative approach to interrogate differences in
the intestinal microbiota between animals, we performed
deep sequencing and metagenomic phylogenetic analysis of
fecal microbiota from the three oldest CF and non-CF pairs1316for which intestinal histopathology was obtained (Figure 7I
and Supplemental Table S1). This culture-independent
method demonstrated considerable diversity in microbiota
between animals, regardless of CFTR genotype. In total, 66
bacterial taxa were identiﬁed from the six animals tested,
including the majority of the bacteria observed by culture
analysis of intestinal samples. Streptococcus was the most
abundant genus observed in all animals (>50%), with the
exception of CF-2 control (Figure 7I), consistent with this
genus being one of the most commonly identiﬁed in the
lungs of CF ferrets by culture.14 Escherichia coli, which has
been shown to be signiﬁcantly more abundant in feces from
children with CF,18 was 2.1- and 7.5-fold higher in abun-
dance in two of the CF animals as compared to their non-CF
paired controls (Supplemental Table S1). On average,
69  6.4% of taxa identiﬁed in the feces of a CF animal
overlapped with its non-CF pair, with three to four majorajp.amjpathol.org - The American Journal of Pathology
Figure 6 Abnormalities in the small intestine
of CF animals. Small intestinal sections from a non-
CF animal (AeC) and three CF animals (DeL)
ranging from 3 to 8 months of age are shown. Each
row of photomicrographs represents a different
animal. H&E (A, D, G, and J) and periodic acid-
Schiff (PAS)-stained sections (B, C, E, F, H, I, K,
and L). A reduction in the height of villi is most
notable in the CF animals (D and G). Mucous
plugging of crypts (arrows, F, I, and L) in CF an-
imals but not in the non-CF control (C) is also
evident by PAS staining. Scale bars: 500 mm (A, D,
G, and J); 200 mm (B, E, H, and K); and 25 mm (C,
F, I, and L).
GI Pathology in Adult CF Ferretstaxa at higher abundance (>1%) being conserved between
each pair (Supplemental Table S1). An ecological measure
of association (Whittaker’s index of association),29,30 which
accounts for species identity and relative abundance,
demonstrated no signiﬁcant clustering by CFTR genotype.
However, when this analysis was performed using the
presence or absence (not abundance) of speciﬁc bacteria, a
nonsigniﬁcant sib-based clustering of the paired animals
was observed. Overall, these ﬁnding suggest that the envi-
ronment (ie, early co-habitation on the jill) more strongly
inﬂuences the fecal microbiome in the ferret than the CFTR
genotype.
At the level of the colon, colonic crypts were dilated with
mucus and often contained bacterial colonies in CF animals.
A mild increase in inﬂammatory cells within the lamina
propria was also observed in CF animals. In one CF animal,
the colon was white in color on gross examination. Histo-
logically the abnormal appearance was due to lym-
phangiectasia with dilation of lymphatic vessels, rupture,
and inﬂammation within the lamina propria and submucosa
(Figure 8, AeF). Rectal prolapse was observed in several
CF animals at approximately 1 month of age (Figure 8,
GeI, and Table 1). Of the 13 animals reported in this study,
two animals were sacriﬁced due to rectal prolapse, and two
others showed signs of early stages of rectal prolapse, but
were rescued by increased use of laxatives. Although rectal
prolapse did not occur in all animals, all CF animalsThe American Journal of Pathology - ajp.amjpathol.orgdemonstrated constipation and diarrhea at different times in
the rearing process. Constipation was treated with increased
GolYTELY (Braintree Laboratories Inc, Braintree, MA)
administration and/or MiraLax (Merck Sharp & Dohme
Corp, Whitehouse Station, NJ), whereas diarrhea was treated
with probiotic. The use of probiotics typically resolved
diarrhea within 3 to 4 days.
Other Organ Abnormalities Are Seen in CF Animals
Abnormalities in the stomach were also observed in 50% of
CF animals older than 1 month of age (Figure 9 and Table 1).
The most common change was submucosal edema (30% of
animals) (Figure 9, B, F, and J) and gastric gland dilation by
mucus (30% of animals) (Figure 9L). In one CF animal (CF-
5), there was gross evidence of digested blood within the
gastric contents indicative of loss of mucosal integrity that
was histologically conﬁrmed as mucosal ulceration with
submucosa edema and inﬂammation (Figure 9, EeH). Two
other CF animals (CF-4 and CF-10) exhibited moderate
mucosal erosion with submucosal edema (Figure 9, IeL).
The ﬁnding of compromised gastric integrity in some CF
animals may be linked to CFTR function in the gastric
glands. Alternatively, because all CF animals failed to thrive
during end-stage disease, these ﬁndings may simply reﬂect
the increased stress that the CF animals are under. In older CF
male animals, the vas deferens was difﬁcult to ﬁnd and absent1317
Figure 7 Bacterial overgrowth occurs in the CF intestine. A: Intestinal tissue at the level of the ileum (with fecal material included) was harvested from six
non-CF and CF animals at 3 to 4 months of age and quantitative culture was performed under aerobic and anaerobic conditions on blood agar. Results depict
the means SEM colony forming unit per mg tissue for NZ 6 independent animals of each genotype. B: The types of bacteria cultured from the non-CF and CF
intestinal samples. Results for bacterial identiﬁcation combined all types of bacteria cultured from the small intestine and colon. The pie charts depict a
semiquantitative prevalence of each strain of bacteria in animals of each genotype. Semiquantitative prevalence was calculated by assigning a categorical
value of 1 if the bacterial strain was detected in a culture and summing these values for all animals in each genotype. Gram-stained small intestine sections
from one non-CF (C and D) and two CF (EeH) animals. Abundant bacterial colonies (arrows) are present within the lumen and occasionally adhered to the
epithelial surface in CF intestine. Scale bars: 500 mm (C); 150 mm (E and G); 25 mm (D, F, and H). I: The fecal microbiota of three pairs of CF and non-CF ferrets.
The bar graph depicts the relative abundance of bacteria within each sample identiﬁed by culture-independent sequence analysis of fecal samples from each
animal. Bacteria with a relative abundance 1% are shown at the genus level. The identifying label of each pair is referenced by the CF animal number (CF-1,
CF-2, and CF-3) given in Table 1; KO-CF animal and control-paired non-CF animal. The longest living CF animals and their non-CF paired control were chosen for
the analysis. Fecal samples were harvested at the following ages for each pair (CF-1 pair, 102 days; CF-2 pair, 162 days, and CF-3 pair, 103 days). Both CF and
non-CF animals within each pair were given the same antibiotics and reared on the same jill until approximately 6 weeks of age (approximately 42 days). *P <
0.05 by Student’s t-test using log transformed colony forming unit titers. Dagger indicates unique bacterial strains found more than once in only non-CF
samples; double dagger (z) indicates unique bacterial strains found more than once in only CF samples.
Sun et alin most sections (Supplemental Figure S3). Infrequently,
remnant islands of vas epithelium (dysplastic and lacking)
could be detected. These changes are consistent with pro-
gressive loss or absence of the vas deferens.Discussion
The goal of this study was to evaluate the progression of
gastrointestinal disease in CF ferrets. Given the extreme
susceptibility of newborn CF ferrets to lung infections,12 all
CF animals were reared on antibiotics with the goal of1318removing them at 6 months of age (the age ferrets are
considered to be sexually mature). Of the 14 CF animals
studied, only four lived beyond the age of 6 months, despite
continued antibiotic therapy. As observed in CF patients,31
CF ferrets develop disease in the pancreas, liver, gall-
bladder, stomach, and intestine to various degrees. Variability
in the severity of disease in these organs of CF patients has
been thought to be due to multiple factors, including the type
ofCFTRmutation, modiﬁer genes, and environment.32,33 Our
results, demonstrating that disease variability exists on a
CFTR null background, emphasize the importance of modi-
ﬁer genes and/or environmental factors in determining CFajp.amjpathol.org - The American Journal of Pathology
Table 2 Culturable Bacteria Observed in the Gut of CF and Non-CF Animals
CF ferret ID Bacterial taxa cultured
CF-3 Enterococcus faecalis, E. faecium, E. gallinarum, Escherichia coli, Lactococcus garvieae, Citrobacter braakii, Clostridium
perfringens, Proteus mirabilis, Pseudomonas putida, Staphylococcus pseudintermedius, Streptococcus alpha hemolytic
CF-3 Control E. faecalis, E. avium, E. hirae, E. coli, Rothia dentocariosa, Veillonella criceti
CF-4 E. faecalis, E. faecium, E. avium, E. coli, Lactococcus lactis, P. mirabilis, S. pseudintermedius, Arthrobacter pigmenti
CF-4 Control E. faecalis, E. faecium, E. avium, E. hirae, E. coli, L. garvieae, L. lactis, Pasteurella canis, P. mirabilis, Streptococcus suis,
Vagococcus ﬂuvialis, V. lutrae, V. criceti
CF-5 E. faecalis, E. faecium, E. gallinarum, E. coli, Klebsiella pneumoniae, P. mirabilis, Streptococcus gallolyticus,
S. lutetiensis, V. ﬂuvialis
CF-5 Control E. faecalis, E. faecium, C. perfringens, E. coli, L. garvieae, P. mirabilis, S. alpha hemolytic, Vagococcus lutrae
CF-9 E. faecalis, E. faecium, E. avium, Lysinibacillus sphaericus, Acinetobacter genomospecies 3, Rothia nasimurium
CF-9 Control E. faecalis, E. coli, Staphylococcus delphini, S. gallolyticus
CF-10 E. faecalis, E. faecium, Staphylococcus hominis, Streptococcus pneumoniae, Penicillium spp.
CF-10 Control E. hirae
CF-11 E. faecium, Staphylococcus epidermidis, S. xylosus
CF-11 Control E. faecalis, Gemella sanguinis, P. mirabilis, S. epidermidis, S. warneri
CF, cystic ﬁbrosis.
GI Pathology in Adult CF Ferretsphenotypes. Given the more controlled environment in which
CF ferrets are reared (ie, housing, chow, etc.), as compared to
humans, modiﬁer genes likely play a more dominant role in
the variability of organ disease severity.
In newborn CF ferrets, pancreatic disease is mild at the
histological level and there is no obvious gallbladder dis-
ease.12,13 Unlike CF pigs, which have fairly uniform and
extensive pancreatic and gallbladder disease at birth,9,11 we
observed variability in the severity of disease in these or-
gans of juvenile and adult CF ferrets. Similar to CF patients,
for which 85% to 90% demonstrate exocrine pancreatic
insufﬁciency,20,21 the majority of the exocrine pancreas was
histologically destroyed in 85% of CF ferrets (11 of 13
animals). Of the CF ferrets older than 1 month of age, 78%
had extensive gallbladder disease characterized by mucosalThe American Journal of Pathology - ajp.amjpathol.orgcystic proliferation with excessive mucus production. This
percentage is much higher than the 15% to 30% of CF
patients who demonstrate histological gallbladder disease at
the time of autopsy.4,34,35
Intestinal complications inCF ferretswere quite diverse and
included rectal prolapse, constipation, and diarrhea at fre-
quencies similar to that observed in CF patients.36,37 Over-
growth of bacteria in the small intestine is a commonﬁnding in
CF mice38 and humans,39 and this was also observed in CF
ferrets. Whether the bacterial overgrowth was the cause or
consequence of villous atrophy frequently observed in the CF
ferrets remains unclear. However, these ﬁndings do suggest
some level of impaired innate immunity in the CF ferret in-
testine, which could result from altered motility of ingesta
and/or nutrients that are not absorbed. Metagenomic deepFigure 8 Pathology of the colon and rectum in
CF ferrets. Histological sections from the colon
from a non-CF (AeC) and CF (DeF) ferret stained
with H&E. Insets in A and D are gross images of
the colon (arrow) demonstrating its white color in
the CF animal. Boxed regions in B and E are
enlarged in C and F, respectively, and show lym-
phangiectasia with dilation of lymphatic vessels in
the CF animal (F). Rectal prolapse in a CF ferret at
28 days of age; gross image (G) and H&E-stained
histology sections (H and I). Boxed region in H is
enlarged in I. Scale bars: 1 mm (A and D); 500 mm
(B, E, and H); and 100 mm (C, F, and I).
1319
Figure 9 Histological abnormalities observed in the gastric mucosa of CF ferrets. Gross images and histological images of the stomach from a non-CF
(AeD) and two CF animals (EeL). Each row of images represents a single animal, depicting the gross image of the stomach (A, E, and I) and various
magniﬁcation of the gastric mucosa (BeD, FeH, and JeL). In this CF animal (EeH), gastric pathology was noted grossly by the multifocal dark areas on the
serosal surface of the stomach (E, inset). The stomach contents contained digested blood indicative of mucosal ulceration. Histologically, there was erosion
and ulceration of the mucosa (arrow, F) with marked submucosal edema (bracketed, F) and inﬂammation (arrowheads, H). A different CF animal (IeL), with
less severe mucosal erosion and submucosal edema and gastric gland dilation (asterisk in L). Interstitial edema and gastric gland dilation were the most
common changes in CF animals. Scale bars: 200 mm (B, F, and J); 100 mm (C, G, and K); and 50 mm (D, H, and L).
Sun et alsequence analysis also demonstrated that Streptococcus,
Enterococcus, and Escherichia were among the most abun-
dant genera found in CF ferret feces. These bacteria are the
predominant pathogens that colonize the lungs of CF ferrets,
representing>80%of culturable bacteria in the lung of 9 of 10
CF animals tested.14 Thus, these ﬁndings reinforce the likely
importance of fecal to oral transfer of pathogens before lung
colonization, as suggested by a recent study in CF infants.40
This study demonstrated that the fecal microbiome signiﬁ-
cantly overlaps with the oropharyngeal microbiome in CF
infants, with pathogens such as Enterococcus, and Escher-
ichia (also observed in CF ferret feces and lungs) increasing in
the stool before oropharyngeal colonization.40
CF ferrets exhibited minor gastric pathology, predomi-
nantly gastric gland dilation with less frequent gastric
mucosal changes (erosion and ulceration). It is presently
unclear if pathological changes in the CF stomach are the
direct result of loss of CFTR function or an indirect
consequence of stress in the animals. However, it is inter-
esting that gastric ulcers have been reported to occur in
>50% of older CF pigs, requiring euthanasia before termi-
nal end-stage lung disease.41 CF-speciﬁc liver disease was
relatively minor in the ferret model when compared to
controls; however, hepatic steatosis and biliary ﬁbrosis were
observed at frequencies similar to CF patients.42
One of the more interesting ﬁndings in the CF ferret
model was the phenotypic variability observed in the extent
of pancreatic disease. Approximately 85% to 90% of CF
patients demonstrate pancreatic exocrine insufﬁciency.20,211320Based on histological criteria, 2 of 12 CF animals had a
predominantly normal exocrine pancreas and maintained
fecal EL-1 levels throughout life that were similar to non-CF
controls. In contrast, CF pig are born with the majority of
their exocrine pancreas destroyed,11 whereas CF mice lack
pancreatic disease.43 This ﬁnding is somewhat surprising,
given that the CFTR genotype has been proposed to
signiﬁcantly inﬂuence pancreatic phenotypes in CF pa-
tients.33 Thus, one could interpret ﬁndings in the CF ferret
model to suggest that either genetic modiﬁers and/or envi-
ronmental factors play an unappreciated role in determining
the extent of exocrine pancreatic damage in CF. However,
because the two pancreatic sufﬁcient CF ferrets (CF-1 and
CF-12) had this phenotype from birth, genetic factors are
likely more important in determining the pancreatic phe-
notypes than the environment. During the ﬁrst year of life,
fecal EL-1 levels in CF infants have been shown to
dramatically ﬂuctuate.44 In this later study, 4 of 82 infants
had fecal EL-1 levels that rose from <200 mg/g at 2 months
of age to >200 mg/g by 12 months of age.44 CF-1 demon-
strated two time points in which fecal EL-1 dropped below
200 mg/g feces within the ﬁrst 35 days of life, whereas CF-
12 maintained fecal EL-1 levels above this threshold for
deﬁning pancreatic insufﬁciency. Very little is known about
the early pathology in the neonatal human CF pancreas
because only indirect measures of function can be used to
interrogate pathology. In humans, the extent of pancreatic
disease has been thought to be due predominantly to the
severity of CFTR mutation. However, because the CFajp.amjpathol.org - The American Journal of Pathology
GI Pathology in Adult CF Ferretsferrets studied were deﬁcient in CFTR, our ﬁndings suggest
that modiﬁer genes are the most likely explanation for the
pancreatic sufﬁciency from birth in CF-1 and CF-12. Such
modiﬁers may include alternative chloride or bicarbonate
channels that compensate for the lack of CFTR. If these
factors could be identiﬁed and manipulated, they could be of
signiﬁcant value to CF patients.
One other ﬁnding about ferret fecal EL-1 levels is worth
noting. There was a signiﬁcant (P < 0.001) increase in fecal
EL-1 levels between 1 to 2 months of age in wild-type control
animals, and this increase also occurred in CF-1. This is the
window in which ferrets are weaned and may account for the
increase. It is presently unclear if similar changes occur in
humans at weaning, however, the fecal EL-1 levels in juve-
nile ferrets are three to four times higher than typically found
in humans.45,46 Thus, this change may be species-speciﬁc.
CF ferrets have been shown to have glucose excursions
>200 mg/dL during the 1- to 2-month period when weaning
occurs,13 and it is possible that a decline in endocrine func-
tion during this time window is linked to increased pressure
on the pancreas to produce pancreatic enzyme.
In summary, our ﬁndings demonstrate that the lack of
CFTR function leads to gastrointestinal disease in juvenile
and adult ferrets in a similar fashion to humans. Interest-
ingly, CF ferrets demonstrated phenotypic variability in the
extent of disease in the liver, pancreas, and gallbladder
similar to that observed in CF patients. The CF ferret model
may be useful in determining the genetic and environmental
inﬂuences responsible for disease variability in CF patients,
and offer an important modality for testing therapies tar-
geting pancreatic, gallbladder, intestinal, and liver disease.
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